By RT-qMSP, the level of SLIT2 promoter methylation was significantly upregulated in the advanced stage compared with the early stage among the tested 6 paired CML patients (Fig. 2). Here, SLIT2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.